Search

Your search keyword '"Tovanabutra, Sodsai"' showing total 512 results

Search Constraints

Start Over You searched for: Author "Tovanabutra, Sodsai" Remove constraint Author: "Tovanabutra, Sodsai"
512 results on '"Tovanabutra, Sodsai"'

Search Results

51. HIV-1 infections with multiple founders associate with the development of neutralization breadth

54. Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth

57. RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection

58. A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1

59. Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection.

60. B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies

61. Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses

62. Declining trend in transmitted drug resistance detected in a prospective cohort study of acute HIV infection in Bangkok, Thailand

63. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes

64. RV144 HIV-1 vaccination impacts post-infection antibody responses

65. Multiple HPV infections among men who have sex with men engaged in anal cancer screening in Abuja, Nigeria

66. Predictors of low CD4 count in resource-limited settings

70. HIV prevalence and risks among injection and noninjection drug users in Northern Thailand: Need for comprehensive HIV prevention Programs

71. Male viral load and heterosexual transmission of HIV-1 subtype E in Northern Thailand

72. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

73. Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom

74. Dynamics of Human Immunodeficiency Virus-1 Genetic Diversification During Acute Infection

75. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge

76. Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand

77. Dendritic Cells Focus CTL Responses Toward Highly Conserved and Topologically Important HIV Epitopes

78. Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

79. HIV infection among female drug users in Northern Thailand

82. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.

83. First CRF01_AE/B recombinant of HIV-1 is found in Thailand

84. Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-Infection Estimation towards Enhanced Vaccine Efficacy Assessment

85. Correction: Trinh, H.V., et al. Humoral Response to the HIV-1 Envelope V2 Region in a Thai Early Acute Infection Cohort. Cells 2019, 8, 365

86. HIV-1 genetic diversity and demographic characteristics in Bulgaria

87. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

88. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

91. Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in northern Thailand

92. Factors influencing estimates of HIV-1 infection timing using BEAST.

93. Multiple condom use and decreased condom breakage and slippage in Thailand

94. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: Use of multiple peptide sets increases the detectable breadth of the CTL response

95. Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection.

96. Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.

98. Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones

99. HIV-1 sequences with more predicted glycans in acute infection were associated with the development of higher neutralization breadth

100. Determinants of CD8+ T Cell Immunodominance in Acute HIV-1 Infection

Catalog

Books, media, physical & digital resources